NOT-EB-24-008: Notice of Extension of the Expiration Date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"

Notice of Extension of the Expiration Date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"

Notice Number:

NOT-EB-24-008

Key Dates

Release Date:

April 16, 2024

Related Announcements

February 23, 2022 - Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed). See PAR-22-000.

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to extend the expiration date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)” by one application due date.

The following section of PAR-22-000 has been modified to reflect the changes:

Part 1. Overview

Key Dates

Currently reads:

Expiration Date May 31, 2024

Modified to read (changes shown in bold italics):

Expiration Date January 30, 2025

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
May 30, 2022	May 30, 2022	Not Applicable	November 2022	January 2023	April 2023
May 30, 2023	May 30, 2023	Not Applicable	November 2023	January 2024	April 2024
May 30, 2024	May 30, 2024	Not Applicable	November 2024	January 2025	April 2025
January 29, 2025	January 29, 2025	Not applicable	July 2025	October 2025	December 2025

All other aspects of PAR-22-000 remain the same.

Inquiries

Please direct all inquiries to:

Dave Gutekunst, Ph.D.
National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
Telephone: 240-789-0004
E-mail: [email protected]